Mobile

A Study examining the treatment effect and Safety of GDC-0853 when compared With Placebo and a biologic therapy (Adalimumab) in Rheumatoid Arthritis Patients who have not responded to Previous therapi...

Mise à jour : Il y a 4 ans
Référence : EUCTR2016-000335-40

A Study examining the treatment effect and Safety of GDC-0853 when compared With Placebo and a biologic therapy (Adalimumab) in Rheumatoid Arthritis Patients who have not responded to Previous therapies

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

• To evaluate the efficacy and safety of GDC-0853 compared with placebo used in combination with stable doses of methotrexate (MTX) in patients (Pts) with active RA who have had an inadequate response (IR) to MTX and are naive to tumour necrosis factor (TNF) therapy

Critère d'inclusion

  • Rheumatoid Arthritis

Liens